Skip to main content
Clinical Trials/NCT04630743
NCT04630743
Completed
Not Applicable

Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease: a Single-arm Therapeutic Exploratory Trial (Phase II)

University of Cologne1 site in 1 country49 target enrollmentFebruary 9, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dyspnea
Sponsor
University of Cologne
Enrollment
49
Locations
1
Primary Endpoint
Enrollment rate (Feasibility)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Episodic breathlessness is a common and distressing symptom in patients with advanced disease such as cancer, chronic obstructive pulmonary disease (COPD) and chronic heart failure. Since the short duration of the majority of breathless episodes limits the effectiveness of pharmacological interventions (e.g. opioids), non-pharmacological management strategies play a major role. As non-pharmacological strategies patients use, for example, cognitive and behavioural methods such as breathing or relaxation techniques.

The aim of the study is to test a brief cognitive and behavioural intervention for an improved management of episodic breathlessness. Initially, a Delphi procedure with international experts has been used to develop the brief intervention consisting of various non-pharmacological strategies to enhance the management of breathless episodes.

In the single-arm therapeutic exploratory trial (phase II), the feasibility and potential effects of the brief intervention, such as patient-reported breathlessness mastery, episodic breathlessness characteristics, quality of life, symptom burden, caregivers' burden, and breathlessness in general will be examined. The results of the study form the basis for planning and implementing a subsequent confirmatory randomized control trial (phase III).

Registry
clinicaltrials.gov
Start Date
February 9, 2019
End Date
March 15, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Steffen Simon

Prfessor Dr Steffen Simon MSc

University of Cologne

Eligibility Criteria

Inclusion Criteria

  • In- and outpatients of the participating centers with episodic breathlessness due to a life-limiting progressive disease
  • Recurrent breathlessness episodes despite optimal treatment of the underlying disease
  • Eastern Cooperative Oncology Group (ECOG) status 0-3
  • Estimated life-expectancy should be at least 8 weeks as judged by the treating physician
  • Ability to understand, read, and respond to German language
  • Informed consent

Exclusion Criteria

  • Episodic breathlessness due to reversible and treatable causes, such as acute pneumonia, pulmonary embolism, chronic hyperventilation syndrome, asthma or other reversible or unknown cause
  • Cognitive impairment
  • Severe current health impairments that do not allow participation after clinical evaluation by the treating physician

Outcomes

Primary Outcomes

Enrollment rate (Feasibility)

Time Frame: week 6

Ratio of patients screened and patients that signed informed consent

Study completion rate (Feasibility)

Time Frame: week 6

Ratio of patients who signed the informed consent and filled out the final assessment

Drop Outs (Feasibility)

Time Frame: week 6

Withdrawal from the study at specific date (e.g. Intervention, refresher, Outcome at week 2/4/6)

Secondary Outcomes

  • Satisfaction with the brief cognitive and behavioral intervention (Acceptability)(week 6)
  • Patients' experience with the Intervention and study procedure(week 6)
  • Potential effects of the brief cognitive and behavioral Intervention on breathlessness mastery(week 2, 4 and 6)
  • Occurence of adverse events due to the study procedure (Safety)(week 6)
  • Potential effects of the brief cognitive and behavioral Intervention on Depression(week 2, 4 and 6)
  • Potential effects of the brief cognitive and behavioral Intervention on Anxiety(week 2, 4 and 6)
  • Occurence of side-effects due to the brief cognitive and behavioral Intervention (Safety)(week 6)
  • Occurence of adverse events due to the brief cognitive and behavioral Intervention (Safety)(week 6)
  • Potential effects of the brief cognitive and behavioral Intervention on Palliative Care needs(week 2, 4 and 6)
  • Potential effects of the brief cognitive and behavioral Intervention on Quality of Life(week 2, 4 and 6)
  • Informal caregivers' burdens while caring for breathlessness patients(week 2, 4 and 6)
  • Potential effects of the brief cognitive and behavioral Intervention on catastrophizing thoughts concerning dyspnea(week 2, 4 and 6)
  • Informal caregivers' experience with Intervention and study procedure(week 6)

Study Sites (1)

Loading locations...

Similar Trials